Task: Answer the multiple choice question.
Question: Which drug exhibits a -88.108\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cn1cc(C(=O)c2cccc(Cl)c2Cl)cc1C#N
(b) N=c1c(C(=O)NC2CCCCC2)cc2c(=O)n3ccccc3nc2n1CCc1ccccc1
Answer: b. N=c1c(C(=O)NC2CCCCC2)cc2c(=O)n3ccccc3nc2n1CCc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N=c1c(C(=O)NC2CCCCC2)cc2c(=O)n3ccccc3nc2n1CCc1ccccc1
N=c1c(C(=O)NC2CCCCC2)cc2c(=O)n3ccccc3nc2n1CCc1ccccc1
N-cyclohexyl-6-imino-2-oxo-7-(2-phenylethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide